Cansortium Stock EBITDA
| CNTMF Stock | USD 0.07 0 4.29% |
Fundamental analysis of Cansortium allows traders to better anticipate movements in Cansortium's stock price by examining its financial health and performance throughout various phases of its business cycle.
Cansortium |
Cansortium OTC Stock EBITDA Analysis
Cansortium's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Cansortium EBITDA | 11.66 M |
Most of Cansortium's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cansortium is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Cansortium reported earnings before interest,tax, depreciation and amortization of 11.66 M. This is 98.67% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 99.7% higher than that of the company.
Cansortium EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cansortium's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cansortium could also be used in its relative valuation, which is a method of valuing Cansortium by comparing valuation metrics of similar companies.Cansortium is currently under evaluation in ebitda category among its peers.
Cansortium Fundamentals
| Return On Equity | -0.28 | |||
| Return On Asset | 0.021 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 118.5 M | |||
| Shares Outstanding | 225.38 M | |||
| Shares Owned By Insiders | 20.98 % | |||
| Shares Owned By Institutions | 0.51 % | |||
| Price To Book | 0.96 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 65.44 M | |||
| Gross Profit | 35.79 M | |||
| EBITDA | 11.66 M | |||
| Net Income | (19.04 M) | |||
| Cash And Equivalents | 8.86 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 53.67 M | |||
| Debt To Equity | 1.89 % | |||
| Current Ratio | 0.73 X | |||
| Book Value Per Share | 0.15 X | |||
| Cash Flow From Operations | (5.03 M) | |||
| Earnings Per Share | (0.1) X | |||
| Target Price | 1.7 | |||
| Number Of Employees | 10 | |||
| Beta | 3.37 | |||
| Market Capitalization | 33.24 M | |||
| Total Asset | 182.46 M | |||
| Net Asset | 182.46 M |
About Cansortium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cansortium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cansortium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cansortium based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Cansortium OTC Stock
Cansortium financial ratios help investors to determine whether Cansortium OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansortium with respect to the benefits of owning Cansortium security.